Home » CALLISTO PHARMACEUTICALS ANNOUNCES COLLABORATION WITH INSTITUTE OF HEPATITIS VIRAL RESEARCH
CALLISTO PHARMACEUTICALS ANNOUNCES COLLABORATION WITH INSTITUTE OF HEPATITIS VIRAL RESEARCH
Callisto Pharmaceuticals, Inc., a developer of novel
drug treatments in the fight against hematological cancers and other diseases
and conditions, today announced a research collaboration with the Institute
of Hepatitis Viral Research (IHVR) to further develop its biodefense program.
The IHVR and the Drexel Institute of Biotechnology and Viral Research (DIBVIR)
are located in Doylestown, PA and are affiliated with Drexel University in Philadelphia,
PA.
Business
Wire
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May